This Project Grant award in the amount of $197,250.00 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award will leverage a time-limited opportunity to study the impact of the Social Worker Outreach and Resource Delivery (SWORD) intervention on individuals bereaved by drug overdose in New York City. The study will compare outcomes of 150 SWORD participants to 150 control participants selected through random...
This federal Project Grant award of $459,045, provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), is for a study titled "The Cascade of Care for Patients with Opioid Use Disorder Identified Through a Large Public Health System." The study aims to modify the existing Opioid Use Disorder (OUD) Cascade of Care model to better reflect the changing landscape of real-world OUD treatment, enabling critical research...
This $1,607,146 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop community-based technology interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to services for people who use drugs. The award supports a participatory approach to create English and Spanish-language multimedia materials, including short videos and graphic novels, to address...
The National Institutes of Health's National Institute on Drug Abuse awarded New York University School of Medicine a $1,446,310 Project Grant under the Drug Abuse and Addiction Research Programs to adapt an evidence-based posttraumatic stress disorder intervention for polysubstance use populations receiving treatment for opioid use disorder. Specifically, the award will support adapting an existing trauma-focused therapy, Skills Training in Affective and Interpersonal Regulation with...
This federal Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $3,233,920.00 to study the prevalence, risk, and protective factors for prolonged grief disorder (PGD) among older adults. The 5-year project, starting on July 12, 2024, will leverage data from three large longitudinal studies to characterize PGD prevalence, identify risk factors, and determine protective factors for this condition. As...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $431,750 to Rutgers, The State University of New Jersey to conduct research on informing national overdose prevention and treatment strategies for high-risk adolescents. The key objectives of this 2-year project are to: 1) estimate the prevalence of adolescent nonfatal drug overdose and identify high-risk demographic and clinical subgroups,...
This $3,096,164 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will support a study to evaluate the efficacy and implementation of a peer-led motivational interviewing intervention to promote the uptake of drug checking services and safer drug use behaviors among people who use drugs in San Diego County. The goal is to reduce the incidence of overdose. The study will involve a two-arm randomized controlled...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to optimize an online behavioral intervention to prevent and reduce substance use among high school seniors, a critical transition period. The $1,702,558 award will fund the development and evaluation of an innovative, technology-driven intervention targeting social influences linked to substance use. The project will employ human-centered...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a $994,004 research study titled "The Youth Empowerment Study (YES)" to explore perceptions of overdose risk, the unregulated drug supply, and safety precautions among adolescents (ages 13-17) and young adults (ages 18-25). The study aims to investigate perspectives of families, youth providers, pharmacists, and people who use...
This $1,264,863 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund research to evaluate the combined efficacy of guanfacine and mindfulness meditation as an adjunct to buprenorphine maintenance treatment for opioid use disorder (OUD). The project will first confirm the independent and combined effects of guanfacine extended release (GXR) and mindfulness-oriented recovery enhancement (MORE) in a sample of...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $3,896,298 to The Leland Stanford Junior University to address prolonged grief and substance use disorders among people bereaved by drug overdose deaths.
The project, titled "Families Left Behind: Addressing Prolonged Grief and Substance Use Disorders Among People Bereaved by Drug Overdose Deaths", involves adapting and piloting a peer-led grief support intervention called "River" for this population. The study will also evaluate the effectiveness of the River intervention compared to enhanced usual care through a randomized controlled trial. The project partners with Peer Support Community Partners, LLC and the RAND Corporation as sub-awardees to develop the intervention, measure fidelity, and conduct the qualitative and quantitative research. This project represents an important effort to support a community heavily impacted by the opioid crisis and provide evidence-based interventions to address their unique grief and substance use challenges.